2024 in Review: Celebrating Milestones and Looking Ahead 

As we step into 2025, we look back on an extraordinary year marked by achievements, growth, and exciting initiatives in 2024.

Throughout the last year, we’ve stayed true to our core values—curiosity, fun, and quality—guiding every step of our journey. Here’s a look back at some of our top highlights, month by month, as well as a glimpse into what’s on the horizon for 2025. 

Here are our top 8 highlights of the year in words and (pictures!):

1. Prix Galien Award for Medical Devices 

A crowning achievement this year was winning the prestigious Prix Galien for Medical Devices. Our innovative solution, VAX-ID, which enables precise and reliable vaccination or drug delivery into the skin, was recognized for its impact and potential. Read more here.

2. Monthly Newsletter Launch 

We kicked off our monthly newsletter series to share updates on skin vaccination, our projects, and team insights. With six editions already published, we’re excited to continue sharing valuable content in the year ahead. Haven’t subscribed yet? Subscribe here. 

3. First Podcast Series 

We launched our inaugural podcast series with special guest Professor Pierre Van Damme from the Centre for the Evaluation of Vaccination (CEV). We followed up with a holiday edition featuring Sander Wuyts, PhD, CEO of ImmuneWatch. Stay tuned for more quarterly podcasts!

4. €3M Series A Funding Secured 

In a significant milestone, we raised €3M in Series A funding to advance our mission of revolutionizing skin drug delivery. Read more here. 

5. Conference Presence 

Our team participated in several key events, including the IPVC, Elsevier Vaccine Conference, Flanders Vaccine Symposium, World Vaccine Congress, and Immunity for Health. These conferences offered fantastic opportunities to connect, share ideas, and grow our network. 

5. Social Media Growth 

Our social media presence soared this year, with 388 new followers, 81,830 organic impressions, and 63 posts. Engaging with our community remains a priority, and we’re excited to keep building connections. Follow us here!

6. Expanding Our Team 

What began as a small team has now grown into a dynamic group of 12 experts specializing in quality assurance, regulatory affairs, business development, clinical affairs, and marketing. Learn more about our team members here. 

*

Looking Forward to 2025 

As we step into the new year, we remain committed to pushing the boundaries of innovation, building on our successes, and continuing to prioritize our values in everything we do. 

Thank you for being part of our 2024 journey. Here’s to an even more exciting 2025! 

Interested in our solutions?

Contact our commercial team!